Tre-O1-03 Response to brentuximab vedotin in advanced stage MF/Sézary syndrome with low CD-30 expression: “real-life” data of the German Cutaneous Lymphoma Network - Blazejak, C; Stranzenbach, R; Klemke, CD (Eur J Cancer, 2021)